Taiwan Agreement Risks Treasury Rewriting Customs Law Globally
On June 1, 2023, the United States and Taiwan signed “the first agreement under the U.S.-Taiwan Initiative on 21st Century Trade.” “Initiative”? “21st Century Trade”?
On June 1, 2023, the United States and Taiwan signed “the first agreement under the U.S.-Taiwan Initiative on 21st Century Trade.” “Initiative”? “21st Century Trade”?
At National Press Club, Katherine Tai talks about supply chain issues, what ‘de-risking’ from China might look like, and how USTR thinks about it.
The House and Senate join forces to remove China, others, from the duty-free ‘de minimis’ import rule.
Three Senators going after China’s “free trade” deal with the United States.
The Coalition for a Prosperous America (CPA) today applauded a new bill by Rep. Jim Banks (R-IN-03) that would ban private pension plans from investing
A Chinese cancer drug maker that has not been inspected by the FDA since 2018 is selling chemotherapy drugs to the U.S. due to shortages. When will the U.S. meet its critical medication needs?
The House Financial Services Committee says American consumers are helped by a strong dollar, which lowers the price of imports to the tune of up to $45 billion per year in savings. In a $23 trillion economy, is an overvalued dollar really worth it?
China as a source for American imports is on the wane thanks to tariffs, other business risks. But strong dollar keeps imports booming.
The balance between scarcity and supply favors supply, even if that means importing drugs from labs the FDA has not inspected.
Meet the Chinese companies banned by Commerce and the State Department, but still able to attract billions from Wall Street fund managers.